Long-term efficacy of vildagliptin in patients with type 2 diabetes undergoing hemodialysis

BACKGROUND: There are few studies evaluating long-term glycemic control using a dipeptidyl peptidase-4 inhibitor in type 2 diabetes patients with end-stage renal disease (ESRD). The aim of this study was to evaluate the safety and efficacy of vildagliptin therapy over 2 years in type 2 diabetes with...

Descripción completa

Detalles Bibliográficos
Autores principales: Mera, Jun-ichiro, Okada, Eiko, Okuda, Masumi, Ota, Tatsuru, Sibata, Shigeru, Uchida, Shunya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635589/
https://www.ncbi.nlm.nih.gov/pubmed/26550558
http://dx.doi.org/10.1186/s40200-015-0214-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635589/
https://www.ncbi.nlm.nih.gov/pubmed/26550558
http://dx.doi.org/10.1186/s40200-015-0214-6

Ejemplares similares